跳至主要内容
临床试验/NL-OMON33150
NL-OMON33150已完成不适用

Incorporation of Multimodality Magnetic Resonance Imaging in the PRIAS study - MRI value in PRIAS

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histologically proven adenocarcinoma of the prostate
  • PSA <= 10 ng/ml and PSA density <0.2 ng/ml/ml
  • TRUS-biopsy Gleason Score <= 6 (no 4 or 5 pattern), TRUS-biopsy
  • characteristics: < 2 cores involved
  • Clinical stage T1C or T2
  • Appropriate biopsy sampling conform PRIAS study

排除标准

  • Patients with known contradictions to MRI
  • Patients with known contra-indications to Gadolinium based contrast agents.
  • Patients with previous therapy for prostate cancer.
  • Patients who can not or do not want to receive curative treatment in form of radiotherapy or radical prostatectomy
  • Patient request for definitive curative intervention

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验